Related Experiment Video
Updated: May 14, 2026

Mitigation of Blood Borne Cell Attachment to Metal Implants through CD47-Derived Peptide Immobilization
Published on: December 3, 2020
Platelet count partially mediates the association between mixed metal exposure and atherosclerotic cardiovascular
Li-Jun Li1, Ying Liu2, Jia Wei2
1The Second Affiliated Hospital, School of Public Health, School of Basic Medicine, Hengyang Medical School, University of South China, Hengyang, Hunan, China; The Key Laboratory of Typical Environmental Pollution and Health Hazards of Hunan Province, School of Public Health, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Insights
Mixed metal exposure, particularly cadmium, strontium, and thallium, increases atherosclerotic cardiovascular disease (ASCVD) risk. Platelet count partially mediates this association, highlighting a novel pathway for ASCVD development.
Area of Science:
- Environmental Health
- Cardiovascular Disease Epidemiology
- Toxicology
Background:
- Platelets play a known role in atherosclerotic cardiovascular disease (ASCVD).
- The impact of mixed metal exposure on ASCVD risk and its relationship with platelet count is not well understood.
- Understanding these interactions is crucial for public health and clinical practice.
Purpose of the Study:
- To investigate the association between exposure to a mixture of metals and ASCVD risk.
- To examine the potential mediating role of platelet count (PLT) in the relationship between metal mixtures and ASCVD.
- To identify specific metals contributing to ASCVD risk through PLT.
Main Methods:
- Case-control study design.
- Weighted Quantile Sum (WQS) regression and Bayesian Kernel Machine Regression (BKMR) to analyze plasma metal mixtures and ASCVD risk.
- LASSO regression and adjusted linear regression to identify key metals and their association with platelet count.
- Mediation analysis to quantify the role of PLT.
Main Results:
- A nine-metal mixture was significantly associated with increased ASCVD risk (OR = 1.89).
- Cadmium (Cd), strontium (Sr), and thallium (Tl) were identified as major contributors to ASCVD risk.
- Cd, Sr, and Tl were positively associated with platelet count (PLT).
- PLT partially mediated the association between Cd, Sr, Tl, and ASCVD risk (mediation proportions: 3.7%, 8.4%, 4.9% respectively).
Conclusions:
- Mixed metal exposure is a significant risk factor for ASCVD.
- Cadmium, strontium, and thallium are key metals driving this association.
- Platelet count plays a modest, partial mediating role in the pathway from metal exposure to ASCVD risk.
Abstract:
The relationship between platelets and atherosclerotic cardiovascular disease (ASCVD) risk has been extensively investigated. However, few studies have explored the interplay among platelets, mixed metal exposure, and ASCVD. This case-control study investigated the association between mixed metal exposure and ASCVD risk, as well as the partial mediating role of platelet count (PLT). Weighted quantile sum (WQS) regression and Bayesian kernel machine regression (BKMR) were used to analyze plasma metal mixtures and ASCVD risk. A nine-metal mixture was positively associated with ASCVD risk (WQS index: OR = 1.89, 95% CI: 1.69-2.12, P < 0.001), with cadmium (Cd), strontium (Sr), and thallium (Tl) as the major contributors, which was further confirmed by LASSO regression. Adjusted linear regression showed that Cd, Sr, and Tl were positively associated with PLT (all P < 0.05). Mediation analysis revealed that PLT partially mediated the association between Cd, Sr, Tl, and ASCVD risk, with mediation proportions of 3.7%, 8.4%, and 4.9%, respectively (all P < 0.05). In conclusion, mixed metal exposure significantly increases ASCVD risk, driven mainly by Cd, Sr, and Tl, with a modest partial mediating effect of PLT.
Related Concept Videos
Atherosclerosis III: Management
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

